The document provides an overview of pneumonia, including classifications, common causes, symptoms, and global impact. It then discusses the specific case of a 6-year-old female patient admitted to the hospital with pneumonia and a urinary tract infection. The objectives of presenting her case are to demonstrate nursing skills, knowledge, and attitudes including applying the nursing process. The case presentation is limited to the 8 hours allotted.
The document provides an overview of pneumonia, including classifications, common causes, symptoms, and global impact. It then discusses the specific case of a 6-year-old female patient admitted to the hospital with pneumonia and a urinary tract infection. The objectives of presenting her case are to demonstrate nursing skills, knowledge, and attitudes including applying the nursing process. The case presentation is limited to the 8 hours allotted.
The document provides an overview of pneumonia, including classifications, common causes, symptoms, and global impact. It then discusses the specific case of a 6-year-old female patient admitted to the hospital with pneumonia and a urinary tract infection. The objectives of presenting her case are to demonstrate nursing skills, knowledge, and attitudes including applying the nursing process. The case presentation is limited to the 8 hours allotted.
I. INTRODUCTION A. Overview of the Case Pneumonia is an inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses. Pneumonitis is a more general term that describes an inflammatory process in the lung tissue that may predispose or place the patient at risk for microbial invasion. Pneumonia and influenza are the most common causes of death from infectious diseases in the United States. Together they account for nearly 60,000 deaths annually and rank as the eighth leading cause of death in the United States (Minino, Heron, Murphy, et al.,2007) Pneumonias are classified as community-acquired pneumonia (CAP), hospital-acquired (nosocomial) pneumonia (HAP), pneumonia in the immunocompromised host, and aspiration pneumonia. There is overlap in how specific pneumonias are classified, because they may occur in differing settings.
CAP occurs either in the community setting or within the first 48 hours after hospitalization or institutionalization. The need for hospitalization for CAP depends on the severity of the pneumonia. The causative agents for CAP that requires hospitalization are most frequently S. pneumoniae, H. influenzae, Legionella, Pseudomonas aeruginosa, and other gramnegative rods. The specific etiologic agent is identified in about 50% of cases. It is estimated that more than 915,000 episodes of CAP occur in adults 65 years of age and older each year in the United States (Mandell, Wunderink, Anzueto, et al., 2007). S. pneumoniae (pneumococcus) is the most common cause of CAP in people younger than 60 years of age without comorbidity .S. pneumoniae, a gram positive organism that resides naturally in the upper respiratory tract, colonizes the upper respiratory tract and can cause disseminated invasive infections, pneumonia and other lower respiratory tract infections, and upper respiratory tract infections, such as otitis media and rhinosinusitis. It may occur as a lobar or bronchopneumonic form in patients of any age and may follow a recent respiratory illness. H. influenzae causes a type of CAP that frequently affects elderly people and those with comorbid illnesses (eg, chronic obstructive pulmonary disease [COPD], alcoholism, diabetes mellitus). The presentation is indistinguishable from that of other forms of bacterial CAP and may be subacute, with cough or low-grade fever for weeks before diagnosis. Mycoplasma pneumonia is caused by M. pneumoniae. Mycoplasma pneumonia is spread by infected respiratory droplets through person-to-person contact. Patients can be tested for mycoplasma antibodies. The inflammatory infiltrate is primarily interstitial rather than alveolar. It spreads throughout the entire respiratory tract, including the bronchioles, and has the characteristics of a bronchopneumonia. Earache and bullous myringitis are common. Impaired ventilation and diffusion may occur. Viruses are the most common cause of pneumonia in infants and children but are relatively uncommon causes of CAP in adults. In immunocompromised adults, cytomegalovirus is the most common viral pathogen, followed by herpes simplex virus, adenovirus, and respiratory syncytial virus. The acute stage of a viral respiratory infection occurs within the ciliated cells of the airways, followed by infiltration of the tracheobronchial tree. With pneumonia, the inflammatory process extends into the alveolar area, resulting in edema and exudation. The clinical signs and symptoms of a viral pneumonia are often difficult to distinguish from those of a bacterial pneumonia.
Overuse and misuse of antimicrobial agents are major risk factors for the emergence of these resistant pathogens. Development of a cough or increased cough and sputum production are common presentations, along with low-grade fever and general malaise. In debilitated or dehydrated patients, sputum production may be minimal or absent. Pleural effusion, high fever, and tachycardia are common. Pneumonia is the single largest cause of death in children worldwide. Every year, it kills an estimated 1.2 million children under the age of five years, accounting for 18% of all deaths of children under five years old worldwide. Pneumonia affects children and families everywhere, but is most prevalent in South Asia and sub-Saharan Africa (http://www.who.int/mediacentre/factsheets/fs331/en/) Pneumonia is among the leading causes of mortality in about five years, ranging from 2004-2008. It ranks no. 4 in the list with about 42,642 cases nationwide contributing to 46.2 rate in 2009 (http://www.doh.gov.ph/node/198.htm) Pneumonia in bukidnon ranks 3 rd in the acute upper respiratory infections which is pertaining to the leading causes of morbidity. It averages from 47,867 cases with rating of 1,273.60. Also it ranks 2 nd in the leading causes of mortality, 1,903 cases with a rating of 50.63. Pneumonia ranks 1 st in infant mortality with cases of 145 and a rating of 1.84 (http://www.popcom.gov.ph/regions/10/Regional%20Profile.htm) Maria Anagonkakai, the subject of the study, a 6 year old female, was admitted last July 26, 2013 and was diagnosed with Pneumonia. The subject was chosen because she ranked first in the scoring made. The subject also resides closer compared to other patients the class has handled which help save time, effort and money. The parents also allowed the class to conduct the said case study with their daughter as the subject of the said study.
B. Objective of the study
General objectives:
At the end of 8 hours case presentation, the students will be able to discuss properly the condition of the client with the use of skills, knowledge and attitudes including the application o nursing process.
Specific objectives: At the end of 8 hours case presentation, the students will be able to Skills: Accurately present of thorough general health assessment of the client which includes physical assessment and family history taking Effectively discuss and collaborate actual signs and symptoms of the disease process by the client with confidence Knowledge: Learn basic and appropriate nursing interventions, treatment plan of prognosis of the disease condition of the patient Understand the normal anatomy and physiology of the affected organ that are affected by the underlying disease condition Attitude: Demonstrate and understand about ones strength and weakness and take measures to enhance ones skills and abilities Able to accept criticism and comments from the clinical instructor Scope of limitation
C. Scope and limitation The scope of the study was to find out more about the patients condition through assessment, interviews with her family, reviewing the patients profile, the doctors orders, the laboratory exams made and interpreting its results and researching and reading more about the patients condition from books, journals and internet sources among others. The scope of the study would also include all the vital information about the patient and her family, her present health condition; the ideal medical and nursing and the actual nursing interventions/care that was done and given to the patient all throughout his confinement at the, BPH-Maramag Pedia Ward. The limitation of the study was the short amount of time that was allotted for the group in giving care to the patient. The patient was given care for 12 hours with actual nursing care done during our hospital rotation. All actual nursing interventions were all carried out with the supervision of a clinical instructor and were limited only to those procedures which were permitted. This study was completed altogether by both research and actual hands-on exposure and interaction with the patient.
I. Health History
A. Patients Profile
Name: Maria AnagonKakai Gender: Female Age: 6 years old Birthdate: August 9, 2013 Birthplace: Maramag, Bukidnon Marital Status: Single Race: Asian Nationality: Filipino Religion: Pentecostal Address: P-1A,San Miguel, Maramag,Buk. Educational Attainment: Elementary Undergraduate Occupation: Student Usual Source of Medical Care: Hospital Source of Information: Mario AnagonKokoi Admitting Diagnosis: Pediatric Community Acquired Pneumonia (CAP) UTI (Urinary Tract Infection) Admitting Physician: Dr. Elaine Aurora A. Castanares
i. CHIEF COMPLAINTS
The patient was apparently well until two weeks ago, the patient suffered with cough which had caused her to have a difficulty of breathing (could not breath when lying) and accompanied with fever and vomiting thus resulting to the admission of the patient at BPH-Maramag.
ii. PAST HEALTH HISTORY No history of hospitalization but has history of cough and fever.
B. HISTORY OF PRESENT ILLNESS Often experiences cough but not addressed properly with no appropriate intervention.
a. Gordons Functional Health Pattern DESCRIPTION PRE-ADMISSION ASSESSMENT INITIAL ASSESSMENT
Health Perception and Health Management
Perceived level of health and well- being, and practices for maintaining health. Habits that may be detrimental to health are also evaluated, including smoking and use of alcohol or other drugs.
Parents seek immediate medical advice once childs illness is serious. Parents let patient use herbal medications (lagundi, hilbas).
Seeks medical advice on July 26, 2013 because of fever accompanied with vomiting and cough which had caused her to have a difficulty of breathing (could not breath when lying) thus resulting to the admission of the patient.
Nutrition and Metabolism
Pattern of food and fluid intake relative to metabolic needs. The adequacy of local nutrient supplies is evaluated.
The client doesnt have any changes on weight. Patients SO described her appetite as good, presently fair and dont have any food intolerances. Doesnt want to eat vegetables as verbalized by the patients father. Usual diet is comprised with processed goods/meat and eats
NPO temporarily except medication. Input and output monitoring every shift.
three times a day. Claimed no known allergies in any foods or drugs.
Elimination Pattern
Excretory patterns (GI, GU, and skin). Incontinence, constipation, diarrhea, and urinary retention may be identified.
Client defecates once in every other day. Usually in the morning. Urinates 2- 3 times a day (50 cc/void).
Patient is in Input and output monitoring and the urine is yellowish in color. Average input of 480 cc / 12 hours. Average output of 100 cc/ 12 hours.
Activity and Exercise Activities of daily living (ADLs) requiring energy expenditure including self-care activities. Assess major body systems involved with activity and exercise including the respiratory, cardiovascular, and musculoskeletal systems. Able to perform activities of daily living as a child. Plays with other children in the community. Active. Weak, tires easily. Unable to perform normal activities of a child. Manifest problem in sleeping noted due to presence of cough and difficulties in breathing. Lethargic and is irritable.
Cognition and Perception
Ability to comprehend and use information. Assess sensory functions. Sensory experiences such as pain and altered sensory input may be identified and evaluated.
Patient is oriented to person, place, and has good memory. Able to comprehend information.
No changes on cognitive and perceptual pattern. Just physically weak.
Sleep and Rest
Sleep, rest, and relaxation practices. Dysfunctional sleep patterns and fatigue
The patient sleeps 6- 8 hours a day. Naps 1-2 times a day. Able to have adequate
Energy level is weak and tires easily. The patient could not really may be identified. rest at night. sleep well because of her cough.
Self-Perception and Self-Concept
Attitudes toward self, including identity, body image, and sense of self-worth. Level of self-esteem and response to threats of self- concept.
According to mother, patient has a good personality, able to deal with other children appropriately. Dependent to her parents.
According to mother, patient has a good personality, but is able to deal with other children appropriately with her current condition. Dependent to her parents.
Roles and relations
Roles in the world and relationships with others. Satisfaction with roles, role strain, or dysfunctional relationships maybe further evaluated.
The patient is the second child of the couple. Able to perform her role as a child. Able also to maintain a good relationship with peers and other siblings.
The patient live with her parents. Bond of the family grew stronger. The attention of the parents turned and focuses to the patient due to her confinement.
Sexuality and Reproduction
Satisfaction and dissatisfaction with sexual patterns and reproductive functions. Concerns with sexuality may be identified.
Patient is a female and is not yet sexually matured. The child is feminine
Patient is a female and is not yet sexually matured. The child is feminine.
Coping and Stress Tolerance
Perceptions of stress and coping strategies. Support systems are evaluated, and symptoms of stress are noted. Effectiveness of coping strategies in
The patient is stress- free. Has a strong support system from family and friends.
The patient is under stress due to her current condition. Copes through sleeping terms of stress tolerance may be evaluated.
Values and Beliefs
Values beliefs, and goals that may guide choices or decisions
The family is affiliated with the Pentecostal church of Christ. They have a strong faith to the almighty father.
The family is affiliated with the Pentecostal church of Christ. They have a strong faith to the almighty father. Theyre praying for the fast recovery of the patient. b. Review by systems and Physical Examination General Health Survey Area/ System Review of system Physical Assessment Nursing Problem Identified Subjective Inspection Palpation Percussion Auscultation Integumentar y No lesions No rashes Color of the skin is pinkish Smooth skin, moist skin Pinkish nail beds and soles Ga uga lagi ang panit sa akong anak maam, dayun luspad ang iya kuku ug mga lapa-lapa, as verbalized by the father. No lesions No rashes Color of the skin is pinkish A bit rough and Dry skin noted Pale nail beds, pale soles
Poor skin turgor Cool skin
----------------- --- ------------------- Deficient Fluid Volume Impaired skin integrity Tissue perfusion, ineffective (cardio pulmonary) related to decreased cellular exchange
Head and Neck No history of headache Nag sakit lagi na iya ulo maam ato pang pagka admit niya pero dili na kayo karun, as verbalized by the father. HEAD Skull is symmetric Asymmetric facial features Hair evenly distributed on scalp Hair color is black
NECK Thyroid is HEAD Absence of masses and lesions noted NECK Absence of palpable masses noted Lymph nodes are not palpable ----------------- --- -------------------- -- Acute pain not visible
Thyroid not palpable
Hair and Nails No history of alopecia No history of nail fungus No verbal cues HAIR Fair distributio n Some lice/ nits noted NAILS Not trimmed
NAILS Capillary Refill beyond 5 seconds
----------------- ---- -------------------- --- Deficient Fluid Volume Tissue perfusion, ineffective (cardio pulmonary) related to decreased cellular exchange
Eyes No history of surgical operation No impaired vision No eyeglasses No contact lenses good eye sight as verbalize by the father Pupils are equally round White sclera Globular eyeballs Black and round iris Pale conjunctiva No lesions Periorbital edema not noted ----------------- ---- -------------------- -- Tissue perfusion, ineffective (cardio pulmonary) related to decreased cellular exchange
Ears No history impaired hearing No No problem as verbalized by the father Skin intact without lesions Cerumen present Both auricles Soft and pliable ----------------- --- -------------------- -- -------------------------------- -------- history of ear infections No hearing aid are level with the both outer canthus of the eyes Nose and Sinus Septum located at midline No obstructi on in nose No pain/tend erness in the sinuses Ge oxygen na lagi na siya maam kay galisud ug ginhawa dayun luya na sad siya maam, as verbalized by the father.
O2 inhalation via nasal cannula at 2-3 L/min Septum located at midline No obstruction in nose
Masses not noted No pain/tenderness in the sinuses ----------------- --- -------------------- -- Impaired gas exchange Fatigue Mouth and Throat No lesions No mass Moist mucous membran es No verbal cues Dry mucous membrane s
----------------------- - ----------------- --- -------------------- -- Impaired Oral Mucous membrane Respiratory No cough Normal breath sounds Luya na lagi kayo na siya maam kay walay undang iya ubo dili sad kaayo gusto makipag istorya O2 inhalation via nasal cannula Tachypnea noted RR=>40bpm ----------------------- -------------- --------- Rales noted Positive of cough Presence of secretions, sputum in Altered Respiratory Pattern Ineffective Airway Clearance Fatigue mam , as verbalized by the father. the airway
Verbal communication, impaired related to physical barriers
Cardiovascula r central Heart Rate within normal limits No murmurs, extra heart sounds No verbal cues -------------------- ------ -------------------------- ----------------- --- Tachycardi a noted HR=>140bp m No murmurs , extra heart sounds Poor tissue perfussion Cardiovascula r Peripheral Pulse palpable Pulse rate within normal range No verbal cues -------------------- --- Pulse is palpable ----------------- ---- Pulse rate above normal limits
Poor tissue perfussion Breast No lesions No mass No verbal cues No lesions noted
No mass noted ----------------- ---- -------------------- --- -------------------------------- -------- Genitourinary System No pain while voiding Good eliminatio No verbal cues No lesion in the genitalia Decreased urinary output ----------------------- ----------------- ----- -------------------- - Urinary retention n pattern No lesions in the genitalia Musculoskele tal No signs of weakness No fractures or use of walkers/ crutches Ge luyahan lang siya mam, pero wala siyay problema sa bahin sa bukog- bukog, as verbalized by the father. No fractures or use of walkers/cru tches -------------------- ----------------- ---- -------------------- - fatigue
c. Genogram
III. Developmental Data 1. Nursing Theories Florence Nightingale: Environmental Philosophy The patient lives in a rural place and quiet environment. It is located near in the syre highway wherein pollution sees as a health threat to the condition of the patient. Their house is made with light materials and half concrete, still for construction. They only have one room and one kitchen for the family which means transmissions of microorganism is easy. They have a poor sanitation at home and do not have a proper bins for their garbage. The family is prone in acquiring diseases such as dengue because of the open drainage soiled with garbage. The family is also prone in acquiring communicable diseases due to the close construction of houses. And on her diet, she doesnt likes to eat vegetables, often eat meat, and drinks 6 to 8 glasses of water per day. Faye Glenn Abdellah. 21 Nursing Problems
The patient was being determined to have some of this problems regarding her health condition such as difficulty in breathing and maintaining physical hygiene, doesnt communicate well with others except for her mother. Inexpressive on her feelings due to her age. All medicine and nursing intervention helped the patient overcome this recognized problem. As a health care partner and nurse should identify the alert and covert problems of the patient before giving the intervention to each identified problems. Virginia Henderson- 14 Basic Human Needs Care includes the following: Breathe normally The patient has oxygen inhalation of 1 to 2-3 l/min since the day of admission Eating drinking adequately The patient was ordered NPO upon admission. Low appetite. Eliminate body waste Chest physiotherapy to remove secretions Maintaining proper physical hygiene Difficulty in expectorating sputum Poor nutrition Does not eat nutritious food such as vegetables Proper ventilation and lighting No air coming into the room at the hospital and aircon is not functional. Manual fanning is given to the patient.
The patient was identified to have some of these problems regarding her health condition. All medicine and nursing intervention helped the patient. As a health care provider, the nurse should identify the overt and covert problems of the patient before giving the intervention to each identified problems.
2. Developmental Theories Developmental theories provide a framework for the psychosocial profile. Identifying patients development stage will help determine the relationship between the patients health status and her growth and development.
Developmental Theories/Theorist Description
A. Sigmund Freuds Psychosexu al Theory Age range: Birth to 1 year- Oral. The patient do not manifest any oral fixation. The patient can drink, eat well and do not manifest biting mannerism. Started talking easy words like mama & papa when she was 6 months old. Breastfeed until she was at 1 year old old and has a complete tooth and satisfied her needs at this level.
Age range: 1 to 3 years- Anal: The patient does not manifest any sign of anal-retentive behaviour or any signs which indicates fixation at this stage. She was also toilet trained during this time but still had nocturnal urination. The patient is independent or has a control on both urination and defecation. The patient doesnt have any catheter attached upon admission as ordered by the Doctor.
Age range: 3 to 6 years- Phallic. The patients dont have any fixation of this stage. The patient is manifesting a normal bond and interaction towards opposite sex. Play with her friends mostly with same gender according to her mother
B. Erik Eriksons Psychosocia l theory. Stage 1: Trust vs. Mistrust. (birth-1 year) Chronologically, this is the period of infancy through the first year of life. The child, well-handled, nurtured, and loved, develops trust and secutity and a basic optimism. Badly handled, she becomes insecure and mistrustful. The patients mother reported that the patient demonstrated physical growth within normal range, was responsive to them through body movements and vocalizations. The patient was breast fed and was drinking breast milk very well. The mother reported that the patient started walking when she was 8 months old.
Stage 2: Autonomy vs. Shame and doubt. (1-3 years) The mother of the patient reported that the client was able to walk alone at about one year old. At this age, the patient already had favourites and was very curious about things around her. The patient holds pencil and started drawing or stroking. She was also toilet trained during this time but still had nocturnal urination. Between the ages of one and three, children begin to assert their independence, by walking away from their mother, picking which toy to play with, and making choices about what they like to wear, to eat, etc. If children in this stage are encouraged and supported in their independence, they become more confident and secure in their own ability to survive in the world. If children are criticized, overly controlled, or not given opportunity to assert themselves, they begin to feel inadequate in their ability to survive, and may then become overly dependent upon others, lack self-esteem, and feel a sense of shame or doubt in their own abilities.
Stage 3: Initiative vs. Guilt. (4-6 years). During the pre-school years, children begin to assert their power and control over the world through directing play, and other social interactions. Children who are successful at this stage feel capable and able to lead others. Those who fall to acquire these skills are left with a sense of guilt, self doubt, and lack of initiatives. The patient has a control of everything. She begin direct playing, and socialized with other child.
Stage 4: Industry vs. Inferiority. This stage cover the early school years from approximately age 5 to 11. Through social interactions, children begin to develop a sense of pride in their accomplishments and abilities. Children who are encouraged and commended by parents and teachers develop a feeling of competence and belief in their skills. Those who received little or no encouragement from parents, teachers, or peers will doubt their abilities to be successful. The patient is socially active. She has a feeling of competence and belief on her skills, she already know how to write and started schooling. She can manifest no doubt on any of her abilities.
C. Jean Piagets Cognitive theory Sensorimotor. This stage lasts from birth to about two years of age. In this stage, the mother reported that the patient constructs an understanding of the world by coordinating sensory experiences such as (seeing and hearing) with physical, motoric action.
Preoperational stage. This stage lasts from approximately two to seven years of age. The patient at this stage begins to represent the world with words, images, and drawings. She started saying mama when she was 6 months old, holding pencil for drawing when she was 3 years old, and can write when she was 5 years old.
IV. Medical Management A. Medical Management and Rationale Summary of Doctors Orders Date Time Doctors Order Rationale July 26, 13
2:05pm
Please admit
Secure consent to care
Problem: fever, cough
Condition: fair
Allergies: none
For proper monitoring, management, and evaluation For the legality of all the procedures to be done to the patient; an evidence that the patient has willingly agreed To identify signs and symptoms Determine the severity of condition To check for allergies that may have caused the
Activity: bed rest, with toilet privilege
Diet: NPO temporarily except meds
Routine nursing care: 1. I &O every shift
2. V/S every 4HR
Start IVF with D50.3% NaCl 3 bottles 500mL @65-70 cc/hr
Labs: 1. CBC with platelet count
2. U/A, please attach
3. OPD result CXR
Meds: 1. Cefuroxime 750 mg/mL, give 700mg IVTT every 6hours ANST 2. Hydrocortisone 270mg IVTT every6HR x 4 doses, 1 st dose then 15mg every 8HR
problems To promote rest and healing
To promote relaxation of GI; client was vomiting PTA
Gauges fluid status that may help in determining the condition of the patient
To monitor for any unusualities or improvement in the patients condition.
To balance out patients electrolytes; for hydration
To determine the general status of the patient
An examination of the urine to detect and measure various compounds that pass through the urine
To have internal visualization of the chest, especially the lungs and the heart.
Bactericidal
Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppressive
July 26, 13
July 27,
7:30 pm
6:00 pm
3. Salbutamol 1 nebule +2cc NSS, nebulize every 15minutes x 3 doses, then every 4HR thereafter
4. Ranitidine 50mg/ampule, give 25mg IVTT every 12HR
5. Ambroxol 75g/mL, give 1.75 mL 3 times a day
6. Cetirizine 5 mg/5mL, give 5mL once a day @ bedtime
7. Paracetamol 250 mg/5mL, give 7.5mL every 4HR pm if temp is 38C
Chest tapping every after nebulisation
Refer accordingly
May give hydrocortisone 15g IV every 8HR, 1 st dose 270mg
produces bronchodilation by stimulating production of cyclic adenosine monophosphate (cAMP)
Inhibits gastric secretion by inhibiting the action of histamine at histamine-2 receptors in gastric parietal cells.
Decreases the viscosity of tenacious secretions by increasing fluid in the respiratory tract.
Compete with histamine to bind to H-1 receptors throughout the body; block histamines effects on body in hypersensitivity or allergic reactions.
Inhibits prostaglandin synthesis in the CNS and stimulate peripheral vasodilation to reduce fever.
Mobilizes secretions
For continuity of care; collaborative treatment between client and health providers. Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppressive. 13
July 28, 13
July 29, 13
Continue meds
May have diet as tolerated
IVFTF D5IMB 2 bottles 500mL @SR
Repeat U/A and CBC with platelet count
Continue nebulisation
IVFTF D5IMB 500mL @SR
Decrease IV fluid rate to KVO rate
Repeat CBC with platelet count
Refer to Dr. Danlag regarding leukocytosis Hold nebulization
Decrease salbutamol nebulisation to every 12HR
Continue meds
Compliance with meds will avert any complications; promote improvement of condition of the patient.
Client can now tolerate any food she desires that is nutritious, if this will not lead to any complications and if the client needs further monitoring for lab test. This solution gives patient calories and keeps them hydrated with water.
To determine any improvement in the results.
Promotes bronchodilation
This solution gives patient calories and keeps them hydrated with water.
To reduce excessive intake of fluid volume
To see if WBC has returned to normal
To confirm leukemia
Patients have tachycardia
Bronchodilators can cause tachycardia
Compliance with meds will avert any complications; promote improvement of condition of the patient.
July 30, 13
Acetylcystein (Falvix) 100 g /sachet, 1 sachet mixed in cup of water 3xa day
UTZ whole abdomen
Kindly place Chest X-ray films at Nurses Station, must officialy read
Discontnue salbutamol nebulisation
Nebulize with salbutamol + ipratropium 1 neb every 4HR
Start clarithromycin 125mg/5mL, 4mL BID, PO
Start cefuroxime
Refer
IVFTF D5IMB 2 bottles 500 mL Decrease mucus viscosity by breaking or altering the chemical bonds of glycoprotein complexes in mucus.
To determine enlargement of organs (could be caused by the accumulation of WBCs since leukemia is suspected)
To have internal visualization of the chest, especially the lungs and the heart. Theres a change of medication
The ipratropium ingredient is an anticholinergic drug which relaxes smooth muscle in the lung. The salbutamol ingredient i sa beta-2agonist whichstimulatesbeta-2 sites in the lungs to relax the bronchi
Inhibits microbial protein synthesis, causing cell lysis.
Inhibits cell-wall synthesis, promoting osmotic instability; usually bactericidal.
For continuity of care; collaborative treatment between client and health providers.
This solution gives patient calories and keeps them
July 31, 13
Aug. 1, 13
4:41pm
(-) tachycardia
Still crackles and @SR
Continue meds.
Follow-up UTZ result
Continue IV meds
Continue nebulization
Secure procurement of meds
IVFTF D5IMB 500 mL at SR
Increase nebulization to every 2 hours
Repeat CBC, platelet count, and CXR (compare with previous film)
Still for CXR
Continue Meds
IVFTF D5IMB 500c @SR
hydrated with water.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
To determine enlargement of organs (could be caused by the accumulation of WBCs since leukemia is suspected)
Compliance with meds will avert any complications; promote improvement of condition of the patient.
Promotes vasodilation.
For compliance of meds
This solution gives patient calories and keeps them hydrated with water.
To loosen secretions
To determine any changes in the condition of the client.
For internal visualization of the chest.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
This solution gives patient calories and keeps them
Aug. 1, 13
Aug. 1, 13
Aug. 2, 13
Aug. 2, 13
wheezes
(+) tachypnea
11:50 am (+) tachypnea (+) crackles and wheezes
O 2 inhalation via nasal cannula @1-2L/min, PRN for dyspnea
Kindly follow up CXR result
Nebulize with Budenoside 1neb q12HR
Monitor V/S q2HR
Continue O 2 inhalation
Continue all meds
Advised
Transfer patient to ICU
Monitor V/S q1HR
NPO temporarily except meds
Labs: Sputum AFB
IVF: D5IMB 500cc @ 70cc/hr
Meds: 1. Hydrocortisone 100mg IVTT, q6HR hydrated with water.
To relief client from shortness of breath.
To determine unusualities and to give immediate intervention Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
To closely examine changes of vital signs To sufficiently supply oxygen to the client
Compliance with meds will avert any complications; promote improvement of condition of the patient. For the continuity of care
To closely monitor the condition of the client and to give immediate interventions when unusualities occur.
To closely examine the clients status
To avoid aspiration pneumonia.
To determine tuberculosis
Make up for the increased urine output.
Aug. 2, 13
Aug. 3, 13
8:10 pm
Decrease urine output (+) tachypnea
2. Piperacillin tazobactam 1.25 g IV q8HR
3. Clarithromycin 125g /5mL, 7.5 mL BID, PO
4. Budenoside 1 neb q12HR
5. Famotidine 10mg IV q12HR
Discontinue other meds
Refer accordingly
May have DAT with SAP
Discontinue Famotidine
Apply cold compress on hypogastric area alternately with warm compress Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppressive.
Inhibit synthesis of bacterial wall and cause rapid cell lysis.
Inhibits microbial protein synthesis, causing cell lysis.
Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
Inhibits gastric secretion by inhibiting the action of histamine at histamine-2 receptors in gastric parietal cells.
There is a change in medication. For continuity of care; collaborative treatment between client and health providers.
Eating is limited and strictly monitored to prevent choking
Patient is already able to ingest food
For client relief and comfort
Aug. 4, 13
Decrease present IVF rate to 50cc/hr
Give furosemide 20mg 1tab now with BP precaution
Decrease hydrocortisone IV q8HR
Decrease O 2 inhalation to 1LPM via nasal cannula
Continue all meds
For repeat CBC
For peripheral blood smear as ordered
Cough patient now then daily (every7am)
Nebulize with salbutamol + ipatropium q4HR
O 2 inhalation to discontinue
Patients RR increases (more than 40)
Inhibit sodium and chloride reabsorption, thereby increasing urine output.
Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppressive
To sufficiently supply oxygen to the client
Compliance with meds will avert any complications; promote improvement of condition of the patient.
To determine changes in the general status of the client
The cell types are examined under a microscope for unusual shapes or sizes.
To religiously secrete phlegm
The ipratropium ingredient is an anticholinergic drug which relaxes smooth muscle in the lung. The salbutamol ingredient i sa beta-2agonist whichstimulatesbeta-2 sites in the lungs to relax the bronchi
Give furosemide 20mg 1 tab now, with BP precaution
IVFTF D5IMB @SR
Resume O 2 inhalation @1, 5LPM via nasal cannula
For observation
Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppressive
This solution gives patient calories and keeps them hydrated with water. Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
For further assessment, management, and evaluation.
This solution gives patient calories and keeps them hydrated with water.
To have internal visualization of the chest, especially the lungs and the heart.
Inhibit sodium and chloride reabsorption, thereby increasing urine output.
This solution gives patient calories and keeps them hydrated with water.
For good oxygenation;
(+) CXR= Pneumonia Continue meds
IVFTF D5IMB @SR
Continue O 2 inhalation
Continue meds
1. Piperacillin + Tazobactam 1.25g IV, q8HR
2. Clarithromycin 125 mg/5mL, 7.5 mL BID PO
3. Prednisone 10mg/5mL, 5mL TID PO
4. Montelukast 5mg 1 tab, OD @HS
5. Salbutamol + Ipratropium 1 neb q4HR
patients RR increase.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
This solution gives patient calories and keeps them hydrated with water.
For oxygenation.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
Inhibit synthesis of bacterial wall and cause rapid cell lysis.
Inhibits microbial protein synthesis, causing cell lysis.
Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
Selectively compete for leukotriene receptor sites, thereby blocking inflammatory action that causes the signs and symptoms of asthma.
The ipratropium ingredient is an anticholinergic drug which relaxes smooth muscle in the lung. The salbutamol
Aug. 6, 13
Aug. 7, 13
6. Budenoside 1 neb q12HR
Furosemide 20mg 1 tab now, with BP precaution
Refer
Decrease IVF rate to 30cc/hr
Place on moderate high back rest
O 2 inhalation to 1LPM via nasal cannula
Nebulize with 1 neb salbutamol + Budenoside 1 neb 30 minutes x 2 doses only
Continue meds
Continue nebulization
Nebulize with 1 neb salbutamol every 20 minutes x 3 doses then resume salbutamol + ipratropium for nebulisation q4HR
Start seretide 25 mg/50mg x 2 puffs BID
ingredient i sa beta-2agonist whichstimulatesbeta-2 sites in the lungs to relax the bronchi Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
Inhibit sodium and chloride reabsorption, thereby increasing urine output.
For further assessment, management, and evaluation.
To avoid fluid overload
Promotes lung expansion
For good oxygenation
To dilate bronchi and loosen secretions
Compliance with meds may avert complications
For continuity of care
To loosen secretions
Selectively activates beta 2adrenergicreceptors, which results in
Aug. 8, 13
Discontinue montelukast
IVFTF D5IMB 500cc @SR
To consume available piperacillin + tazobactam
Continue other meds
Discontinue O 2 inhalation
Refer accordingly
May transfer to ward
V/S every 4 hours
Diet for age
Continue meds
1. Salbutamol + Ipratropin 1 neb q4HR
2. Budenoside 1 neb q12HR bronchodilation and blocks the release of allergic mediators from the mast cells in the respiratory tract
Change of medication
This solution gives patient calories and keeps them hydrated with water. For continuity of care
Compliance with meds may avert complications For oxygenation
For further assessment, management, and evaluation.
Stable vital signs; does not need more immediate interventions. To monitor for any unusualities or improvement in the patients condition.
Appropriate nutrition for the patient
Compliance with meds will avert any complications; promote improvement of condition of the patient.
The ipratropium ingredient is an anticholinergic drug which relaxes smooth muscle in the lung. The salbutamol ingredient i sa beta-2agonist
Aug. 8 ,13
Aug. 9, 13
4:30pm (+) wheezes and crackles
3. Clarithromycin 125 mg/5mL, 7.5 mL BID PO
4. Prednisone 10mg/5mL, 5mL TID PO
5. Seretide 25mg/50mg x 2 puffs BID
IVFTF D5IMB 500cc @SR
O 2 inhalation 2-3 LPM via nasal cannula PRN for dyspnea/SOB
Please refer accordingly
Thank you
Decrease Salbutamol + Ipratropin neb timing to q6HR
whichstimulatesbeta-2 sites in the lungs to relax the bronchi
Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
Inhibits microbial protein synthesis, causing cell lysis.
Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing.
Selectivelyactivates beta 2adrenergicreceptors, whichresults inbronchodilation andblcks the release of allergic mediatorsfrom the mast cellsin the respiratorytract
This solution gives patient calories and keeps them.
For good oxygenation
For further assessment, management, and evaluation.
Aug. 9, 13
Aug. 9, 13
12:40pm Still with productive cough but decreased frequency Decreased crackles and wheezes
Continue other meds
Follow up result for peripheral blood smear
Continue present meds
IVFTF D5IMB 2 bottles 500cc @SR
Repeat urinalysis
Follow up result of Chest X-ray (#3)
Follow up peripheral blood smear
MGH once with official results
Home meds
OPD check-up on August 12, 2013
There is an improvement of the patients cough.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
The cell types are examined under a microscope for unusual shapes or sizes.
Compliance with meds will avert any complications; promote improvement of condition of the patient.
This solution gives patient calories and keeps them.
An examination of the urine to detect and measure various compounds that pass through the urine.
To have internal visualization of the chest, especially the lungs and the heart.
The cell types are examined under a microscope for unusual shapes or sizes.
Stable or there is an improved condition.
Compliance with meds will
Fairly advised
Home per request avert any complications; promote improvement of condition of the patient.
Follow-up and for monitoring the condition; continuity of care.
For compliance
Client request to go home; right of the client to make decision
B. Drug study NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Cefuroxime
Second- generation Cephalosporins Treatment for infections of the lower respiratory tract Used cautiously with patients allergic to penicillins; those with history of GI disease (particularly Colitis)
Nausea Vomiting Diarrhea Anaphyla xis Pseudom embrano us colitis 12 rights of drug administration
Obtain patients allergy history before administering drug
Observe for signs and symptoms of BRAND NAME:
Ceftin
DATE ORDERED
July 26, 2013
MECHANISM OF ACTION:
Inhibits cell- wallsynthesis, promoting osmotic instabi lity;usually bactericidal. allergic reactions after giving drug, discontinue the drug and notify the physician immediately if reaction occur
DOSE:
750mg/mL, give 700mg
FREQUENC Y:
Every 6 hours ROUTE:
IVTT
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATIO N CONTRAINDICAT ION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Hydrocortis one
Corticosteroids (Glucocorticost eroids) Treat respiratory tract diseases Contraindicated in patients with CNS: Headache, dizziness, fatigue, neuropsychi atric effect 12 rights of drug administration
Enters target cells and binds to cytoplasmic receptors; initiates many complex reactions that are responsible for its anti- inflammatory, immunosuppre ssive (glucocorticoid )
DOSE:
15 mg
FREQUENC Y:
Every 8 hours
ROUTE:
IVTT
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Albuterol
Bronchodilator Treat acute bronchospa sm
Patients with uncontrol led arrhythmi as, hyperten sion, CAD, or history of stroke Used cautiousl y in patients with diabetes, hyperthyr oidism, or history of seizures
Anxiety Nervousne ss Tremor Tachycardi a Palpitation Hypertensi on Arrhythmia s Dry mouth Bronchosp asm Hypokalem ia in dialysis patients
Monitor the patients v/s as well as breath sounds
Dont administer drug during acute asthma attack
Instruct patient to maintain fluid intake
Instruct the patient to avoid respiratory irritants such as smoke, dusts, and strong scents
BRAND NAME: Salbutamol DATE ORDERED
July 26, 2013
MECHANISM OF ACTION:
produces bronchodilatio n by stimulating production of cyclic adenosine monophosphat e (cAMP) DOSE:
1 neb + 2cc NSS
FREQUENC Y:
Every 12 hours
ROUTE:
Inhalation
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Ranitidine
Histamine-2 Receptor Antagonists Decrease gastric acid production and prevent stress ulcers in severely ill patients
Breast- feeding patients Known hypersenstiv ity Used cautiously in pregnant patients, with impaired renal or hepatic function, and elderly patients
Headache Dizziness Confusion Mild diarrhea
Teach the patient that smoking worsens ulcer disorders and counteracts the effects of H-2 antagonists
Dont give antacid within 1 hour of administering drug; it may decrease absorption of drug
Assess for epigastric or abdominal pain
Teach to avoid gastric irritants such as smoking, alcohol BRAND NAME:
Zantac DATE ORDERED
July 26, 2013
MECHANISM OF ACTION:
Inhibits gastric secretion by inhibiting the action of histamine at histamine-2 receptors in gastric parietal cells. DOSE:
50mg/amp, give 25mg
FREQUENC Y:
Every 12 hours
ROUTE:
IVTT
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATIO N CONTRAINDICAT ION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Ambroxol Expectorant Treat cough associated with bronchial athma
Contraindicated in patients with hypersensitivity
Used cautiously in patients with ineffective cough reflex or respiratory insufficiency.
Vomiting (if taken in large doses), diarrhoea, nausea, drowsiness, and abdominal pain. 12 rights of drug administration
Maintain airway patency, provide suction if necessary
Assess breath sounds, evaluate the characteristics of cough and frequency
Instruct to maintain fluid intake.
BRAND NAME:
Aeroflux
DATE ORDERED: July 26, 2013
MECHANISM OF ACTION: Decrease the viscosity of tenacious secretions by increasing fluid in the respiratory tract. DOSE:
1.75 mL
FREQUENC Y:
TID
ROUTE:
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Cetirizine
antihistamine Symptomati c relief of symptoms
Patients with previous history of allergiv reactions Shouldnt in patients with allergy to hydroxyzi ne Narrow- angle glaucoma , BPH, or asthma
GI upset CNS depression and CNS effects (disturbed coordinatio n) Dryness of mouth, throat, and nose Increased respiratory secretions Increased heart rate Fever, rash palpitation s
Observe signs and symptoms of hypersensitivity reactions
Administer drug with food or milk to decrease GI irritation
Withhold drug if the patient is scheduled to receive an allergy skin test
Use Z-track method if giving drug parenterally
BRAND NAME:
Zyrtec DATE ORDERED
July 26, 2013
MECHANISM OF ACTION:
Compete with histamine to bind to H-1 receptors throughout the body; block hitamines effects on body in hypersensitivit y or allergic reactions DOSE:
5mg/5mL, give 25mg
FREQUENC Y:
Once a day
ROUTE:
IVTT
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Paracetam ol
Nonopioid Analgesics; Antipyreitc Reduce fever Used cautiously in patients with asthma or nasal polyps
GI pain and upset Nausea and vomiting Diarrhea
For a more rapid effect, administer the drug before meals, to reduce GI irritation, administer with meals Monitor CBC, platelet, and hepatic and renal function tests Dont administer more than the recommend ed dosage because of increased risk of toxicity BRAND NAME:
Biogesic DATE ORDERED
July 26, 2013
MECHANISM OF ACTION:
Inhibits prostaglandin synthesis in the CNS and stimulate peripheral vasodilation to reduce fever DOSE:
250mg/5m L, give 5mL FREQUENC Y:
Q4hr PM if temp is 38C
ROUTE:
Oral
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Acetylcyste ine
Mucolytics Treat abnomrla , viscid, or thick and hard mucus Patients with known hypersensitivi ty
Used cautiously in elderly, debilitated, pregnant, or breast- feeding patients and those with asthma
Nausea and vomiting Bronchosp asms, especially in asthmatic patients
Maintain airway patency; suction if necessary Assess patients breath sounds, evaluate cough for characteristi c Encourage patient to increase fluid intake Warn the patient about acetylcystei nes rotten egg smell BRAND NAME:
Flavix DATE ORDERED
July 29, 2013
MECHANISM OF ACTION:
decrease mucus viscosity by breaking or altering the chemical bonds of glycoprotein complexes in mucus DOSE:
100g/sache t, 1 sachet mixed in cup of water FREQUENC Y:
3x a day
ROUTE:
Oral
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Salbutamol + Ipratropiu m
Anti asthmatic; adrenergic- agonist bronchodilator Prevention and maintenanc e therapy for bronchospa sms Patients with uncontrolled arrhythmias, hypertension, coronary heart disease, or history of stroke
Palpitation s Tachycardi a Arrhythmia s Hypertensi on Increases severity of any asthma episodes that occur
Monitor the patients v/s as well as breath sounds
Dont administer drug during acute asthma attack
Instruct patient to maintain fluid intake
Instruct the patient to avoid respiratory irritants such as smoke, dusts, and strong BRAND NAME:
Combivent DATE ORDERED
July 29, 2013
MECHANISM OF ACTION:
The ipratropium ingredient is an anticholinergic drug which relaxes smooth muscle in the lung. The DOSE:
1 neb FREQUENC Y:
Q4hr
salbutamol ingredient i sa beta-2agonist whichstimulates beta-2 sites in the lungs to relax the bronchi scents ROUTE:
inhalation
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATIO N CONTRAINDICAT ION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Budenoside Corticosteroids Control bronchial asthma
Prophylacti c treatment for exercise- induced asthma Contraindicated in patients with bronchospasms
Used with extreme caution in patients with clinical tuberculosis or viral respiratory infections, etc.
Mouth irritation, oral candiasis, and upper respiratory infections 12 rights of drug administration
Instruct the patient to rinse mouth after using inhaled steroids
Instruct on proper use and care of inhaler and spacer
Give oral doses with food to minimize GI upset BRAND NAME:
Pulmicort DATE ORDERED
August 1, 2013
MECHANISM OF ACTION: Prevent release of or counteract biochemical DOSE:
1 neb
mediators that cause the tissue inflammation responsible for edema and airway narrowing. FREQUENC Y:
Every 12 hours
ROUTE:
P.O
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Peppiracilli n/Tazobact am
Extended- spectrum Penicillins Treat infections caused by gram- negative bacteria (Nosocomia l or CAP) Patients with hypersensitivi ty with penicillins and/or cephalosporin s
GI pain and upset Nausea and vomiting Diarrhea Rash
Obtain patients allergy history before administerin g the drug Know that an allergic reaction to penicillin may occur even in patients BRAND NAME:
Zosyn DATE ORDERED
MECHANISM OF ACTION:
August 2, 2013
Inhibit synthesis of bacterial wall and cause rapid cell lysis with no history of allergic reactions Observe signs and symptoms for allergic reactions Instruct the patient to avoid taking oral penicillin with acidic juices, may reduce drug absorption DOSE:
1.25g FREQUENC Y:
Q8hr
ROUTE:
IV
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Clarithrom ycin
Antibiotic (Miscellaneous Anti- Infectives) Treat infections caused by gram- positive and gram- Hypersen- sitivity toclarithro- mycin, other macroli de
GI: diarrhea, nausea,vo miting, abdominal
Before:- Note sensitivity toerythromy cin or BRAND NAME:
Biaxin negative organisms, pneumococ ci antibiotics,or erythro- mycin.Clients takingpimozid e.
pain CNS: headache, dizziness,h allucinatio n,insomnia , Allergic: urticaria,mi ld skin eruption,a naphylactic anymacrolid e antibiotics. List drugs currentlypre scribed to preventany interactions. Document onset,severi ty andcharacte ristics of S&S.Durin g: May administer withor without food. Explain effects of the drug and its sideeffects. Administer asprescribed .After: Report adverse effects or lack of improvem ent after 48- 72 hr. DATE ORDERED
July 29, 2013
MECHANISM OF ACTION:
Inhibits microbial protein synthesis, causing cell lysis and cell death DOSE:
125mg/5m L, give 4mL FREQUENC Y:
BID
ROUTE:
Oral
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATIO CONTRAINDICAT ION ADVRESED/ TOXIC NURSING RESPONSIBILITIE N EFFECTS S GENERIC NAME:
Monteluka st Antasthmatic
Leukotriene receptor antagonist Treatment for Asthma Contraindicated in patients with previous allergy to any leukotriene modifier
Shouldnt be used for treatment of status asthmaticus r acute asthma attacks
Know that montelukast is best absorbed when given at night.
Instruct about the use of rescue medication for acute attacks or when a short- acting inhaled medications is needed.
BRAND NAME:
Singulair
DATE ORDERED: July 26, 2013
MECHANISM OF ACTION: Selectively compete for leukotriene receptor sites, thereby blocking inflammatory action that causes the signs and symptoms of asthma. DOSE: 5 mg
FREQUENC Y: O.D ROUTE: P.O
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Famotidine Histamine-2 Receptor Antagonists Decrease gastric acid production and prevent stress ulcers in severely ill patients
Breast- feeding patients Known hypersenstiv ity Used cautiously in pregnant patients, with impaired renal or hepatic function, and elderly patients
Headach e Dizziness Confusio n Mild diarrhea
Teach the patient that smoking worsens ulcer disorders and counteracts the effects of H-2 antagonists
Dont give antacid within 1 hour of administering drug; it may decrease absorption of drug
Assess for epigastric or abdominal pain
Teach to avoid gastric irritants such as smoking, alcohol BRAND NAME:
Pepcid DATE ORDERED
August 2, 2013
MECHANISM OF ACTION: Inhibits gastric secretion by inhibiting the action of histamine at histamine-2 receptors in gastric parietal cells. DOSE:
10 mg
FREQUENC Y:
Every 12 hours
ROUTE:
IV
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Furosemid e
Potassium- sparing Diuretic Increase urine output Contraindicat ed with allergy to furosemide, sulfonamides. Use dcautiously with diabetes mellitus./ with metabolic disorders.
Nausea and vomiting Constipatio n Orthostatic hypotensio n
Arrange to monitor sodium and potassium serum electrolyt es.
Give early in the day so that increased urination will not disturb sleep.
Blood glucose levels may become temporarily elevated in patients with diabetes after starting this drug.
Give medications as ordered that will help loosen stools in case of constipation.
BRAND NAME:
Lasix DATE ORDERED
Aug. 2, 2013
MECHANISM OF ACTION:
Inhibit sodium and chloride reabsorption, thereby increasing urine output.
DOSE:
20 mg FREQUENC Y:
Now
ROUTE:
Oral
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATIO N CONTRAINDICAT ION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Prednisone Cortecosteroid s Control bronchial asthma
Contraindicated in patients with bronchospasms
Used with extreme caution in patients with clinical tuberculosis or viral respiratory infections, etc
Mouth irritation, oral candiasis, and upper respiratory infections 12 rights of drug administration
Instruct the patient to rinse mouth after using inhaled steroids
Instruct on proper use and care of inhaler and spacer
Give oral doses with food to minimize GI upset BRAND NAME:
Deltasone DATE ORDERED: Aug. 6, 2013
MECHANISM OF ACTION: Prevent release of or counteract biochemical mediators that cause the tissue inflammation responsible for edema and airway narrowing. DOSE: 5 mg
FREQUENC Y: O.D ROUTE: P.O
NAME OF DRUG CLASSIFICATIO N SPECIFIC INDICATION CONTRAINDIC ATION ADVRESED/ TOXIC EFFECTS NURSING RESPONSIBILITIE S GENERIC NAME:
Salmetrol+ Fluticasone
Anti asthmatic; adrenergic- agonist bronchodilator Prevention and maintenanc e therapy for bronchospa sms Patients with uncontrolled arrhythmias, hypertension, coronary heart disease, or history of stroke
Palpitation s Tachycardi a Arrhythmia s Hypertensi on Increases severity of any asthma episodes that occur
Monitor the patients v/s as well as breath sounds
Dont administer drug during acute asthma attack
Instruct patient to maintain fluid intake
Instruct the patient to avoid respiratory irritants such as smoke, dusts, and strong scents BRAND NAME:
Seretide DATE ORDERED
Aug. 7, 2013
MECHANISM OF ACTION:
Selectivelyactiv ates beta 2adrenergicrec eptors, whichresults inbronchodilati on andblcks the release of allergic mediatorsfrom the mast cellsin the respiratorytrac t DOSE:
250mg/50 mg x 2 puffs FREQUENC Y:
BID
ROUTE:
Oral
C. Diagnostic and Laboratories July 26, 2013 DIAGNOSTIC TEST/NORMAL VALUES
RESULT INTERPRETATION SIGNIFICANCE Hematology: Hemoglobin (11- 16gms) 13.1 Normal Normal Hematocrit (37- 47vol%) 39.1 Normal Normal WBC (5,000- 10,000/cu.mm) 24,900/cu.mm Above normal limits Infection Platelet (150,000- 450,000/cu.mm) 418,000/cu.mm Normal Normal Segmenters (55-65%) 44% Below normal limits Infections Lymphocytes (25- 35%) 53% Above normal limits Infections Monocytes (2-4%) 03% Normal Normal
U/A Specific gravity (1.015-1.020) 1.020 Normal Normal Pus cell (0-1) 1.5 Above normal Infections RBC (3-5 hpf) 0-1 Below normal Anemia
July DIAGNOSTIC TEST/NORMAL VALUES
RESULT INTERPRETATION SIGNIFICANCE CBC Hemoglobin (11- 16gms) 14.6 Normal Normal Hematocrit (37- 47vol%) 44.4 Normal Normal WBC (5,000- 10,000/cu.mm) 46,500/cu.mm Above normal limits Infections Platelet (150,000- 450,000/cu.mm) 406,000/cu.mm Normal Normal Segmenters (55-65%) 41% Below normal limits Infections Lymphocytes (25- 35%) 51% Above normal limits Infections Monocytes (2-4%) 02% Normal Normal Eosinophils (2-4%) 06% Above normal limits Allergies
U/A Specific gravity (1.015-1.030) 1.015 Normal Normal Pus cell (0-1) 2.0 Above normal limits Infections RBC (3-5) 1-3 Below normal limits Anemia
July DIAGNOSTIC TEST/NORMAL VALUES
RESULT INTERPRETATION SIGNIFICANCE Hematology: Hemoglobin (11- 16gms) 13.6 Normal Normal Hematocrit (37- 47vol%) 40.9 Normal Normal WBC (5,000- 43,600/cu.mm Above normal limits Infections 10,000/cu.mm) Platelet (150,000- 450,000/cu.mm) 308,000/cu.mm Normal Normal Segmenters (55-65%) 51% below normal limits Infections Lymphocytes (25- 35%) 45% Above normal limits Infections Monocytes (2-4%) 04% Normal Normal
August 1, 2013 DIAGNOSTIC TEST/NORMAL VALUES
RESULT INTERPRETATION SIGNIFICANCE Hematology: Hemoglobin (11- 15.8 Normal Normal 16gms) Hematocrit (37- 47vol%) 49.1 Normal Normal WBC (5,000- 10,000/cu.mm) 35,400/cu.mm Above normal limits Infection Platelet (150,000- 450,000/cu.mm) 439,000/cu.mm Normal Normal Segmenters (55-65%) 38% Below normal limits Infections Lymphocytes (25- 35%) 55% Above normal limits Infections Monocytes (2-4%) 07% Above normal limits Infections
August 4, 2013 (ICU) DIAGNOSTIC RESULT INTERPRETATION SIGNIFICANCE TEST/NORMAL VALUES
Hematology Hemoglobin (11- 16gms) 13.1 Normal Normal Hematocrit (37- 47vol%) 40.7 Normal Normal WBC (5,000- 10,000/cu.mm) 40,200/cu.mm Above normal limits Infections Platelet (150,000- 450,000/cu.mm) 415,100/cu.mm Normal Normal Segmenters (55-65%) 30% Below normal limits Infections Lymphocytes (25- 35%) 65% Above normal limits Infections Monocytes (2-4%) 04% Normal Normal Eosinophils (1-4% 01% Normal Normal
August 8, 2013 PERIPHERAL SMEAR Smear shows normochromic and normocytic red cells. The white blood cells count estimate is increase normal range with predominance of lymphocytes. No immature forms seen. Platelets are adequate in number.
SPUTUM EXAMINATION AFB = 0
ULTRASOUND RESULT Whole abdomen The liver is normal in size and tissue attenuation. The intrahetaptic ducts are not dilated. No focal lesions noted. The gallbladder is normal in size and configuration. No wall thickening, abnormal intraluminal echos and calculi demonstrated. The pancreas is normal in sizeand parenchymal echo. No focal lesions noted here. No enlarged lymph nodes or mass appreciated in the vicinity of the abdominal aorta. The spleen is normal in size. No focal lesions noted. Splenic hilum is unremarkable. There is no significant disparity in size, shape, and location of the kidneys. DIMENSION RIGHT KIDNEY LEFT KIDNEY In Length 8.5cm 8.6cm Cortical Thickness 1.0cm 1.0cm Both kidneys exhibit hypoechoic parenchyma relative to the liver and spleen. The central echo-complexes are normal. The pelvocalyceal system and ureters are not dilated. No focal lesions and calculi appreciated. The urinary bladder is adequately filled showing regular contour and smooth walls. No abnormal echo or calculi noted intraluminally. No mass lesions noted in bilateral adnexae Chest x-ray result (July 26, 2013) Hazy densities are seen in both inner lung zones. The heart is not enlarged. Both hemidiaphragm and cp sulci are intact. Rest of included structures are unremarkable. Chest x-ray result (July 31, 2013) Hazy densities are seen in both inner lung zones. The heart is not enlarged. Both hemidiaphragm and cp sulci are intact. Rest of included structures are unremarkable.
V. Anatomy and Physiology The respiratory system
General Function A primary requirement for all body cell activities and growth is oxygen, which is needed to obtain energy from food. The fundamental purpose of the respiratory system is to supply oxygen to the individual tissue cells and to remove their gaseous waste product, carbon dioxide. Breathing, or ventilation, refers to the inhalation and exhalation of air. Air is a mixture of oxygen, nitrogen, carbondioxide and other gases; the pressure of these gases varies, depending on the elevation above sea level. The first, called external expiration, takes place only in the lungs, where oxygen from the outside air enters the blood and carbondioxide leaves the blood to be breathed into the outside air (Figure 10-1). In the second, called internal respiration, gas exchanges take place between the blood and the body cells, with oxygen leaving the blood and entering the cells at the same time that carbon dioxide leaves the cells and enters the blood. The respiratory system is an intricate arrangement of spaces and passageways that conduct air into the lungs. These spaces include the nasal cavities; the pharynx, which is common to the digestive and respiratory systems; the voice box, or larynx; the windpipe, or trachea; and the lungs themselves, with their conducting tubes and air sacs. The entire system might be thought of as a pathway for air between the atmosphere and the blood.
Structure and Function of Respiratory Pathways The Nasal Cavities Air makes its initial entrance into the body through the openings in the nose called the nostrils. Immediately inside the nostrils, located between the roof of the mouth and the cranium, are the two spaces known as the nasal cavities. These two spaces are separated from each other by a partition, the nasal septum. The septum and the walls of the nasal cavities are constructed of bone covered with mucous membrane. From the lateral (side) walls of each nasal cavity are three projections called the conchae. The conchae greatly increase the surface over winch air must travel on its way through the nasal cavities. The lining of the nasal cavities is a mucous membrane, which contains many blood vessels that bring heat and moisture to it. The cells of this membrane secrete a large amount of fluid. It is better to breath through the nose than through the mouth because of changes produced in the air as it comes in contact with the lining of the nose: 1. Foreign bodies, such as dust particles and pathogens, are filtered out by the hairs of the nostrils or caught in the surface mucus. 2. Air is warned by the blood in the vascular membrane. 3. Air is moistened by the liquid secretion The sinuses are small cavities lined with mucous membrane in the bones of the skull. The sinuses communicate with the nasal cavities, and they are highly susceptible to infection.
Figure 10-1. Diagram of external respiration showing the diffusion of gas molecules through the cell membranes and throughout the capillary blood and air in the alveolus. (From Memmler and Wood: The Human Body in Health and Disease, ed 6, Philadelphia, 1987, J. B. Lippincott co.)
The Pharynx The muscular pharynx (throat) carries air into the respiratory tract and foods and liquids into the digestive system. Theupper portion located immediately behind the nasal cavity is called the nasopharynx , the middle section located behind the mouth is called the oropharynx, and the lowest portion is called the laryngeal pharynx. This last section opens into the larynx toward the front and into the oesophagus toward the back.
The Larynx The larynx (voice box) is located between the pharynx and the trachea. It has a framework of cartilage that protrudes in the front of the neck and sometimes is referred to as the Adams apple. The larynx is considerably larger in the male than in the female; hence, the Adams apple is much more prominent in the male. At the upper end of the larynx are the vocal cords, which serve in the production of speech. They are set into vibration by the flow of air from the lungs. A difference in the size of the larynx is what accounts for the difference between the male and female voices; because a mans larynx is larger than a womans, his voice is lower in pitch. The nasal cavities, the sinuses, and the pharynx all serve as resonating chambers for speech, just as the cabinet does for a stereo speaker. The space between these two vocal cords is called the glottis, and the little leaf-shaped cartilage that covers the larynx during swallowing is called the epiglottis. The epiglottis helps keep food out of the remainder of the respiratory tract. As the larynx moves upward and forward during swallowing, the epiglottis moves downward, covering the opening into the larynx. You can feel the larynx move upward toward the epiglottis during this process by placing the flat ends of your fingers on your larynx as you swallow. The larynx is lined with ciliated mucous membrane. The cilia trap dust and other particles, moving them upward to the pharynx to be expelled by coughing, sneezing, or blowing the nose.
The Trachea (Windpipe) The trachea is a tube that extends from the lower edge of the larynx to the upper part of the chest above the heart. It has a framework of cartilages to keep it open. These cartilages, shaped somewhat like a tiny horseshoe or the letter C, are found along the entire length of the trachea. All the open sections of these cartilages are at the back so that the esophagus can bulge into this section during swallowing. The purpose of the trachea is to conduct air between the larynx and the lungs.
The Bronchi and Bronchioles The trachea divides into two bronchi which enter the lungs. The right bronchus is considerably larger in diameter than the left and extends downward in a more vertical direction. Therefore, if a foreign body is inhaled, it is likely to enter the right lung. Each bronchus enters the lung at a notch or depression called the hilus or hilum. The blood vessels and nerves also connect with the lung in this region.
The Lungs The lungs are the organs in which external respiration takes place through the extremely thin and delicate lung tissues.The two lungs, set side by side in the thoracic cavity, are constructed in the following manner: Each bronchus enters the lung at the hilus and immediately subdivides. Because the subdivision of the bronchi resembles the branches of a tree, they have been given the common name bronchial tree. The bronchi subdivide again and again, forming progressively smaller divisions, the smallest of which are called bronchioles. The bronchi contain small bits of cartilage, which give firmness to the walls and serve to hold the passageways open so that air can pass in and out easily. However, as the bronchi become smaller, the cartilage decreases in amount. In the bronchioles there is no cartilage at all; what remains is mostly smoothly muscle, which is under the control of the autonomic nervous system. At the end of each of the smallest subdivisions of the bronchial tree, called terminal bronchioles, is a cluster of air sacs, resembling a bunch of grapes. These sacs are known as alveoli. Each alveolus is a single-cell layer of squamous (flat) epithelium. This very thin wall provides easy passage for the gases entering and leaving the blood as it circulates through millions of tiny capillaries of the alveoli. Certain cells in the alveolar wall produce surfactant, a substance that prevents the alveoli from collapsing by reducing the surface tension (pull) of the fluids that line them. There are millions of alveoli in the human lung. Because of the many air spaces, the lung is light in weight; normally a piece of lung tissue dropped into a glass of water will float. As mentioned the pulmonary circuit brings blood to and from the lungs. In the lungs blood passes through the capillaries around the alveoli, where the gas exchange takes place.
The Lung Cavities The lungs occupy a considerable portion of the thorax cavity, which is separated from the abdominal cavity by the muscular partition known as the diaphragm. Each lung is enveloped in a double sac of serous membrane called the pleura. The portion of the pleura that is attached to the chest wall is called parietal pleura, while the portion that is reflected onto the surface of the lung is called visceral pleura. The pleural cavity around the lungs is an air-tight space with a partial vacuum, which causes the pressure in this space to be less than atmospheric pressure. Because the pressure inside the lungs is higher than that in the surrounding pleural cavity, the lungs tend to remain inflated. The entire thoracic cavity is flexible, capable of expanding and contracting along with the lungs. The region between the lungs, the mediastinum, contains the heart, great blood vessels, esophagus, trachea, and lymph nodes.
Physiology of Respiration Pulmonary Ventilation Ventilation is the movement of air into and out of the lungs, as in breathing. There are two phases of ventilation (Figure10-3): 1. Inhalation is the drawing of air into the lungs. 2. Exhalation is the expulsion of air from the lungs. In inhalation, the active phase of breathing, the respiratory muscles contract to enlarge the thoracic cavity. The diaphragm is a strong dome-shaped muscle attached around the base of the rib cage. The contraction and relaxation of the diaphragm cause a piston-like downward motion that result in an increase in the vertical dimension of the chest. The rib cage is also moved upward and outward by contraction of the external intercostals muscles and, during exertion, by contraction of other muscles of the neck and chest. During quiet breathing, the movement of the diaphragm accounts for most of the increase in thoracic volume.
Figure 10-3. (A) Inhalation. (B) Exhalation (Source: Carola, R., Harley,J.P., Noback R.C., (1992), Human anatomy and physiology, Mc Graw hill inc, New York, 2nd ed,) As the thoracic cavity increases in size, gas pressure within the cavity decreases. When the pressure drops to slightly below atmospheric pressure, air is drawn into the lungs. In exhalation, the passive phase of breathing, the muscles of respiration relax, allowing the ribs and diaphragm to return to their original positions. The tissues of the lung are elastic and recoil during exhalation. During forced exhalation, the internal intercostals muscles and the muscles of the abdominal wall contracts, pulling the bottom of the rib cage in and down. The abdominal viscera are also pushed upward against the diaphragm.
Air Movement Air enters the respiratory passages and flows through the ever-dividing tubes of the bronchial tree. As the air traverses this passage, it moves more and more slowly through the great number of bronchial tubes until there is virtually no forward flow as it reaches the alveoli. Here the air moves by diffusion, which soon equalizes any differences in the amounts of gases present. Each breath causes relatively little change in the gas composition of the alveoli, but normal continuous breathing ensures the presence of adequate oxygen and the removal of carbon dioxide.
Table 10-1 gives the definition of and average values for some of the breathing volumes that are important in any evaluation of respiratory function.
Table 17-1 Breathing Volumes Volume Definition Average volume Tidal volume The amount of air moved into or out of the lungs in quiet, relaxed breathing 500 cc Vital capacity The volume of air that can be expelled from the lungs by maximum exhalation following maximum inhalation 4800 cc Residual capacity The volume of air that remains in the lungs after maximum exhalation 1200 cc Total capacity The total volume of air that can be contained in the lungs after maximum inhalation 6000 cc Functional residual capacity The amount of air remaining in the lungs after normal exhalation 2400 cc
Regulation of respiration Regulation of respiration is a complex process that must keep pace with moment-to- moment changes in cellular oxygen requirements and carbon dioxide production. Regulation depends primarily on the respiratory control centers located in the medulla and pons of the brain stem. Nerve impulses from the medulla are modified by the centers in the pons. Respiration is regulated so that the levels of oxygen, corbon dioxide, and acid are kept within certain limits. The control centers regulate the rate, depth, and rhythm of respiration. From the respiratory center in the medulla, motor nerve fibers extend into the spinal cord. From the cervical (neck) part of the cord, these nerve fibers continue through the phrenic nerve to the diaphragm. The diaphragm and the other muscles of respiration are voluntary in the sense that they can be regulated by messages from the higher brain centers, notably the cortex. It is possible for a person to deliberately breath more rapidly or more slowly or to hold his breath and not breath at all for a time. Usually we breath without thinking about it, while the respiratory centers in the medulla and pon do the controlling. Of vital importance in the control of respiration are the chemoreceptors. These receptors are found in structures called the carotid and aortic bodies, as well as out side the medulla of the brain stem. The carotid bodies are located near the bifurcation of the common carotid arteries, while the aortic bodies are located in the aortic arch. These bodies contain many small blood vessels and sensory neurons, which are sensitive to decreases in oxygen supply as well as to increases in carbon dioxide and acidity (H+). Impulses are sent to the brain from the receptors in the carotid and aortic bodies. The receptor cells outside the medulla are affected by the concentration of hydrogen ion in cerebrospinal fluid (CSF) as determined by the concentrations of carbon dioxide in the blood. VI. Nursing Care Plan Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation SUBJECTIVE CUES: Dili kayo siya kaginhawa, galisud siya ug ginhawa, s verbalized by the father. Complaints of weakness as reported by the father Ineffective Airway Clearance related to accumulation of secretions in the respiratory tract Short Term Objective: At the end of 3 hours of nursing intervention the patient will be able to: Expectorate sputum Breath deeply & cough to remove secretions When helping patient cough & deep-breathe, use whatever position best ensures cooperation & minimizes energy expenditure, such as high fowlers position or sitting on side of bed. Teach patient an easily performed cough technique
Encourage sputum expectoration. Provide containers for the sputum.
Such positions promotes chest expansion & ventilation of basilar lung fields.
To clear airway without fatigue
To remove pathogens & prevent the spread of At the end of 3 hours of nursing interventi on the patient was able to expectorat e about 5- 10 cc of sputum & was able to cough it out. Patients Name: Shekeanah U. Sacay Date: August 1, 2012. 2. Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation SUBJECTIVE CUES: Galisud siya ug ginhawa, as verbalized by SO. Ineffective Breathing Pattern related to decreased energy or fatigue Short term Objective: At the end of five hours of nursing intervention the patient will be able to: Achieve maximum lung expansion with Assist patient to a comfortable position, such as supporting upper extremities with pillow to lean on, & elevating head of bed. Teach patient about: Pursed-lip breathing Abdominal breathing These measures promote comfort, chest expansion & ventilation of basilar lung fields. These measures allow patient to participate in At the end of 5 hours of nursing intervention the patient was not able to achieve maximum lung expansion with OBJECTIVE CUES: RR= 40 cpm Use of alar muscles
Cause Analysis: Associated medical diagnosis: Pneumonia Long Term Objective: At the end of 12 hours of nursing intervention the patient will be able to: Maintain a patent airway Have an adequate ventilation Achieve oxygen level at a normal range as evidenced by a normal RR
Give expectorants, bronchodilators & other drugs, as ordered & monitor effectiveness. Encourage fluids, increase intake Provide bronchodilators treatment before chest physiotherapy Turn patient every two hours always position for maimal aeration of lung fields & mobilization of secretions
infection. These measures enhance clearance of secretions from airways. To liquefy secretions To optimize results
This prevents pooling and stasis of respiratory secretions
At the end of 12 hours of nursing intervention the patient was not able to maintain a patent airway & has needed to have O 2
supplementatio n. Instructions already given. adequate ventilation Performing relaxation technique Taking prescribed meds Scheduling activities to avoid fatigue & provide rest periods Auscultate breath sounds at least every 4 hours
Assess & record respiratory rate & depth at least every 4 hours
maintaining health status and improve ventilation
To detect decreased or adventitious sounds; report changes To detect early signs of respiratory compromise inadequate ventilation aided with 0 2 inhalation. OBJECTIVE CUES: Accessory muscle use Shortness of breath Nasal flaring Altered respiratory rate=40 cpm Cause Analysis: Associated medical diagnosis: Pneumonia Long term Objective: At the end of 12 hours of nursing intervention the patient will be able to: Report feeling comfortable when breathing At the end of 12 hours of nursing intervention the patient was not able to report feeling of being comfortable when breathing with O 2 inhalation via nasal cannula.
3. Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation SUBJECTIVE CUES: Complaints of difficulty in breathing by the patient & SO Impaired Gas Exchange related to Altered oxygen supply Short Term Objective: At the end of 5 hours of nursing intervention the Assess & record pulmonary status every 4 hours or if patients condition is unstable Place patient in position that For pulmonary status may result in hypoxemia To enhance gas At the end of 5 hours of nursing intervention the patient was patient will be able to: Have normal breath sounds Expectorate sputum best facilitates chest expansion Change patients position at least every 2 hours
Perform bronchial hygiene as ordered including coughing, percussion, postural drainage and even suctioning. Record intake and output
Report signs of dehydration or overload
Teach patient relaxation techniques exchange To mobilize secretions & allow aeration of all lung fields. These measures promote drainage & keep airways clear. To monitor patients fluid status Dehydration may hinder tissue perfusion & secretion mobilization; fluid overload may cause pulmonary edema. To reduce tissue oxygen demand. not able have normal breath sounds as evidenced by rales upon auscultation but has expectorated some of the sputum. OBJECTIVE CUES: Nasal flaring Use of accessory muscles Altered HR=140 bpm & RR=40cpm Cause Analysis: Associated medical diagnosis: Pneumonia Long term Objective: At the end of 12 hours of nursing intervention the patient will be able to have her HR and RR within normal range At the end of 12 hours of nursing intervention the patient was not able to achieve HR & RR within normal limits, with the latest HR of 140 and RR of 40.
(*O 2 inhalation given monitored every two hours)
4. Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation SUBJECTIVE CUES: Ga uga lagi ang panit sa akong anak maam, dayun luspad ang iya kuku ug mga lapa-lapa, as verbalized by the father. Deficient Fluid Volume related to active loss Short Term Objective: At the end of 3 hours of nursing intervention the patient will be able to: Have Stable vital signs Have normal Skin color evaluations Have her Fluid volume remain adequate Have normal skin turgor Monitor and record vital signs every 2 hours or as often as necessary until stable, then monitor and record vital signs every 4 hours Cover patient lightly. Avoid overheating.
Measure intake and output every 1 to 4 hours. Report and record significant changes. Include urine, stools, vomitus and other output. Assess skin turgor and oral mucous membranes every 8 hours Give meticulous mouth Tachycardia, dyspnea, or hypotension may indicate fluid volume deficit or electrolyte imbalance.
To prevent vasodilation, blood pooling in extremities, and reduced circulating blood volume. Low urine output and high specific gravity indicate hypovolemia.
To check for dehydration.
To avoid dehydrating At the end of 3 hours of nursing intervention the patient was not able to have Stable vital signs but the patient was able to have normal skin color evaluations, have her fluid volume remain adequate and patients skin turgor became normal.
OBJECTIVE CUES: A bit rough and Dry skin noted Pale nail beds, pale soles Poor skin turgor Pale conjuctiva
Cause Analysis: Associated medical diagnosis: Pneumonia Long Term Objective: At the end of 12 hours of nursing intervention the patient will be able to: Have normal fluid and blood volume care every 4 hours Dont allow patient to sit or stand up quickly as long as circulation is compromised
Administer and monitor medications Explain reasons for fluid loss, and teach significant others of patient how to monitor fluid volume-for example, by measuring intake and output. mucous membranes To avoid orthostatic hypotension and possible syncope
To prevent further fluid loss This encourages patients SO involvement in personal care. At the end of 12 hours of nursing intervention the patient was able to have normal fluid and blood volume as evidenced by normal skin color evaluations, but conjunctiva remains pale.
5. Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation SUBJECTIVE CUES: dayun luspad ang iya kuku ug mga lapa- lapa, as verbalized by the father. Ineffective Tissue Perfusion (Cardiopulm onary) related to decreased cellular exchange Short Term Objective: At the end of 3 hours of nursing intervention the patient will be able to: have a warm skin have a normal skin color evaluation have achieve fluid balance, with intake and output Monitor patients heart rate and rhythm until stable, then every two hours record and report any changes above or below established limits. Monitor skin color and temperature every 2 hours. Monitor respiratory rate and depth every hour until stable, then every 2 to 4 hours. Record and report changes outside established limits.
Measure and record urine output every hour until output exceeds 30ml/hr then every 2 to 4 hours. *If patient has no history of renal disease, urine output is a good indicator of tissue perfusion. Relieve anxiety and pain.
Change patients position regularly, following turning schedule, inspect his skin every shift, record and report any potential areas of Decreased heart rate can indicate hypovolemia, which leads to decreased tissue perfusion. Cool skin indicates decreased tissue perfusion.
Increased respiratory rate is a compensatory mechanism of tissue hypoxia that can result from decreased tissue perfusion. Decreased or absent urine output usually indicates poor renal perfusion.
Anxiety and pain can cause a sympathetic reaction that results in vasoconstriction and decreased tissue perfusion. These measures avoid decreased tissue perfusion and the risk of skin breakdown. At the end of 3 hours of nursing intervention the patient was able to have a warm skin, a normal skin color evaluation and was able to achieve fluid balance, with intake and output OBJECTIVE CUES: Capillary Refill beyond 5 seconds Pale conjunctiva Cool skin
Cause Analysis: Associated medical diagnosis: Pneumonia Long Term Objective: At the end of 12 hours of nursing intervention the patient will be able to: Exhibit improved circulation as evidenced by a capillary refill less than 5 seconds, and a normal skin color evaluation At the end of 12 hours of nursing intervention the patient was able to exhibit improved circulation as evidenced by a capillary refill less than 5 seconds, and a normal skin color evaluation. 6. breakdown. Assessment Data/Cues Nursing Diagnosis Objectives of Care Nursing Care Plan Rationale Evaluation
SUBJECTIVE CUES: Luya na lagi kayo na siya maam kay walay undang iya ubo dili sad kaayo gusto makipag istorya mam , as verbalized by the father. Fatigue Short Term Objective: At the end of 3 hours of nursing intervention the patient will be able to: Feel comfortable and report absence of tiredness Prevent unnecessary fatigue; for example, avoid scheduling many energy draining procedures at the same time.
Conserve energy through rest, planning and setting priorities Reduce demands placed on patient; for example, ask one family member to call at specified times and relay messages to friends and other family members Encourage patient to eat foods rich in iron and minerals, unless contraindicated. Postpone eating when patient is fatigued Avoid highly emotional situations Encourage SO to feed the patient with nutritious foods which are rich in vitamins and minerals like fruits and vegetables. Using energy conserving techniques avoids overexertion and potential for exhaustion. To prevent or alleviate fatigue To reduce physical and emotional stress.
This helps avoid anemia and demineralization. To avoid aggravating the condition. To avoid aggravating the condition. To boost the patients immune system and helps in her recovery from her condition.
At the end of 3 hours of nursing intervention the patient was able to report absence of tiredness as evidenced by jolly interaction with the health practitioners but still the patient was not feeling comfortable as manifested by irritability of patient. OBJECTIVE CUES: Lack of energy Lethargic
Cause Analysis: Associated medical diagnosis: Pneumonia Long Term Objective: At the end of 12 hours of nursing intervention the patient will be able to: Regain strength as evidenced by active participation in her health regimen At the end of 12 hours of nursing intervention the patient was able to regain strength as evidenced by active participation in her health regimen. 79
Case Presentation Le Donneur 15 Pneumonia
VII. Discharge and Prognosis Summary GOOD FAIR POOR
a. Physiologic response of the body to disease process / b. Relief of symptoms associated with disease condition / c. Performance of the activities of the patient during / confinement (e.g. eating toileting, dressing, etc.) d. Compliance of the patient to the medication and/or / therapy e. Adequacy of rest periods and sleep / f. Consumption of the patient with nutrition and therapeutic / regimen g. Patients significant others behaviour regarding the / health teaching given by the physician Calculations Formula: amount # of (good, fair,poor) X 100 = (percentile) 7 Amount of Percentile Good = 2 28.57 Fair = 3 42.86 Poor = 2 28.57 Interpretation: The result shows that the patient has a fair prognosis has fair responses of her body to disease process, fair to cope performance of the activities during confinement, fair to have adequate rest periods and sleep, poor relief of symptoms associated with disease condition, poor consumption of with nutrition and therapeutic regimen, also ,... has good compliance of the patient to medication and/or therapy and good patients significant others behaviour regarding the health teaching given by the physician. 80
Case Presentation Le Donneur 15 Pneumonia
III. APPENDIX a. Vital signs Monitoring
0 20 40 60 80 100 120 140 160 July 26, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM July 27, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM Heart rate Respiratory rate Temperature 81
Case Presentation Le Donneur 15 Pneumonia
0 20 40 60 80 100 120 140 160 July 28, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM July 29, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM Heart rate Respiratory rate Temperature 82
Case Presentation Le Donneur 15 Pneumonia
0 20 40 60 80 100 120 140 160 July 30, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM July 31, 2:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM 10:00 PM Heart rate Respiratory rate Temperature 83
Case Presentation Le Donneur 15 Pneumonia
0 20 40 60 80 100 120 140 160 180 August 1, 10:00 AM 2:00 PM 4:00 PM 6:00 PM 10:00 PM 2:00 AM 6:00 AM 6:00 AM Heart rate Respiratory rate Temperature 84
0 20 40 60 80 100 120 140 August 8, 1:00 AM 2:00 AM 3:00 AM 4:00 AM 5:00 AM 6:00 AM 10:00 AM 2:00 PM 6:00 PM August 9, 2:00 AM 6:00 AM 10:00 AM 2:00 PM Heart rate Respiratory rate Temperature 92
Case Presentation Le Donneur 15 Pneumonia
Legend: Black- Normal Blue - Below normal Red- Above Normal 93
Case Presentation Le Donneur 15 Pneumonia
BLOOD PRESSURE MONITORING 94
Case Presentation Le Donneur 15 Pneumonia
DATE & TIME RESULT JULY 26, 2013 2:00 AM 100/60 AUGUST 2, 2013 (8AM-8PM) 3:00PM 90/70 4:00PM 90/70 5:00PM 90/60 6:00PM 90/70 7:00PM 90/60 AUGUST 2, 2013 (8PM-8AM) 8:00PM 90/60 9:00PM 90/60 10:00PM 90/60 11:00PM 90/60 12:00MN 90/70 1:00AM 90/70 2:00AM 90/60 3:00AM 90/70 4:00AM 100/70 4:00AM 90/60 5:00AM 100/60 6:00AM 90/70 7:00AM 90/60 AUGUST 3, 2013 (8AM-8PM) 8:00AM 100/70 9:00AM 100/70 10:00AM 110/80 11:00AM 100/70 12:00NN 90/65 1:00PM 90/60 2:00PM 100/70 95
8:00AM 90/70 9:00AM 100/60 10:00AM 90/60 11:00AM 90/60 12:00NN 90/60 DATE & TIME RESULT AUGUST 7, 2013 (8AM-8PM) 1:00PM 90/60 2:00PM 90/60 3:00PM 90/60 4:00PM 90/60 5:00PM 90/60 6:00PM 90/60 7:00PM 90/70 AUGUST 7, 2013 (8PM-8AM) 8:00PM 90/70 9:00PM 90/70 10:00PM 90/70 11:00PM 90/70 12:00MN 90/70 1:00AM 90/70 2:00AM 90/70 3:00AM 90/70 4:00AM 90/70 5:00AM 90/70 6:00AM 90/60 7:00AM 90/60 AUGUST 8, 2013 (8AM-8PM) 10:00 AM 90/60 2:00PM 100/70 6:00PM 90/70 AUGUST 8, 2013 (8PM-8AM) 10:00PM 90/60 2:00AM 90/60 6:00AM 90/60 AUGUST 9,2013 (8AM-8PM) 10:00AM 90/60 2:00PM 90/60 6:00PM 90/60 DATE & TIME RESULT AUGUST 8, 2013 (8PM-8AM) 10:00PM 90/60 2:00PM 90/50 97
Case Presentation Le Donneur 15 Pneumonia
b. Intake and Output July 29. 2013 Shift IVF IVTT P.O. Oth ers Total Urin e Stool Oth ers Total 3 am- 8 pm 130 scc 0 350 cc 0 480 cc 100 cc 0 0 100 cc
August 2, 2013 Shift IVF IVTT P.O. Oth ers Total Urin e Stool Oth ers Total 3 am- 8 pm 50 cc 7 cc 180 cc 0 192 cc 350 cc 0 0 350 cc 8 pm - 8am 720 cc 13.1 cc 80 cc 0 213 cc 0 0 0 0
August 3, 2013 Shift IVF IVTT P.O. Oth ers Total Urin e Stool Oth ers Total 8 am- 8 pm 560 cc 7 cc 280 cc 0 847 cc 430 cc once 0 430 cc 8 pm - 8am 560 cc 13.1 cc 240 cc 0 813 cc 155 cc once 0 155
August 5, 2013
August 6, 2013 Shift IVF IVTT P.O. Oth ers Total Urin e Stool Oth ers Total 8 am- 8 pm 360 cc 11 cc 150 cc 0 521 cc onc e 0 0 once 8 pm - 8am 360 cc 5.5 cc 300 cc 0 665.5 cc 400 cc once 0 400 cc
Shift IVF IVTT P.O. Othe rs Total Urin e Stool Oth ers Total 8 am- 8 pm 600 cc 5.5 cc 280 cc 0 600.5 5 cc 580 cc 0 0 580 cc 12 pm - 4am 250 cc 11.1 cc 240 cc 0 461 cc onc e 0 0 1 cc 98
Case Presentation Le Donneur 15 Pneumonia
Urine and stool output
July 26,2013 July 27,2013 July 28,2013 July 29, 2013 July 30 ,2013 July 31,2013 Urine 8 pm- 8 am 2 2 2 3 3 4 8 am- 8 pm 1 1 0 2 2 1 Stool 8 pm- 8 am 0 0 1 1 2 2 8 am- 8 pm 0 0 0 1 1 0
August 1, 2013 August 2, 2013 August 3, 2013 August 4, 2013 August 5, 2013 August 6, 2013 Urine 8 pm- 8 am 3 0 0 0 2 3 8 am- 8 pm 0 0 0 0 0 0 Stool 8 pm- 8 am 0 0 0 1 0 0 8 am- 8 pm 0 0 1 1 0 0
August 7, 2013 August 8, 2013 August 9, 2013 Urine 4 4 2 99
Medication Salbutamol + Ipratropine nebule, 1 nebule every 6 hours (10 am-4 pm- 10 pm- 4 am) Budesomide nebule, 1 nebule every 12 hours (8 am- 8 pm) Clarithromycin nebule, 7 ml 2x a day, 5 more days (8 am-8 pm) Montelukast, 1 tab. Once a day at hour of sleep (8 pm) Senetide 25/80g inhaler, 2 puffs a day (8 am- 6 pm) Exercise ROM Deep breathing Treatment Stress reduction (yoga, reading and other relaxing activities) Chest physiotherapy Health Teaching Provide information on balancing food intake, brochodilator agents and energy expenditure. How and when to take medication Teach on the things that can trigger asthma Out Patient Consult with a dietitian about specific dietary needs based on patients current condition. Instruct to return on August 12, 2013 fo follow up check-up. Diet Diet as tolerated fruits, higher fiber (wheat) & low fat content (low fat milk products, low fat dairy/commercial products). Avoid foods which are eggs, dairy products, soy, nuts, etc. That can trigger asthma. Increase fluid intake into 3-4 liters per day
101
Case Presentation Le Donneur 15 Pneumonia
REFERENCE Bombrys, A.E. et.al. (2008). Retrieved last February 28, 2013. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621052/.
Doenges, Moorehouse, M.F. & Murr, A.C. (2010). NursesPocket Guide : Diagnosis, Prioritized Interventions and Rationales. Philadelphia, Pennsylvania:F.A Davis Company
Luxner, K. L. (2005). Delmar's Maternal Infant Nursing care Plans. Singapore: DELMAR LEARNING.
Norwitz, E.R. Preeclampsia. Retrieved last March 1, 2013. Retrieved from www.mayoclinic.com Delmars nurses Drug Hand Book. (2010) Spratto, G.R. & Woods, A.L. (2010). Delmars Nurses Drug Handbook. United States of America: Delmar Cengage Learning Ralph, S.S. & Taylor, C.M. (2005). Nursing Diagnosis Reference Manual